Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome
Clinical trial NCT05701774 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05701774
- Sponsor
- Soleno Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-31
- Primary completion
- 2028-06-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.